OrthoPediatrics Expands Direct Sales in Belgium, the Netherlands
OrthoPediatrics updated an agreement with Hospithera to act as its exclusive sales agency in Belgium and the Netherlands. Jan 07, 2019
SpineEx Withdraws $17MM IPO
SpineEx, developer of an expandable device for minimally invasive lateral lumbar interbody fusion, withdrew its plans for a US $17MM initial public offering late in 4Q18. Jan 07, 2019
Episurf Medical Gains Another US Patent
Episurf Medical received another Notice of Allowance from the USPTO, addressing image segmentation used for 3D joint damage visualization as well as the design of patient-specific implants and instruments. Jan 03, 2019
Histogenics to Explore Strategic Alternatives for NeoCart Cartilage Treatment
Histogenics plans to evaluate the range of potential strategic alternatives for its NeoCart® cell therapy following FDA's indication that an additional clinical trial would be required before acceptance of a Biologics License Application submission. Jan 03, 2019
JointPoint Gains Clearance for Digital Navigation in Canada
JointPoint obtained Health Canada licenses for ELITE and PRO surgical navigation systems, allowing for immediate deployment of these products in the region. Jan 03, 2019
Zimmer Biomet Gains FDA Clearance for ROSA Knee System
Zimmer Biomet received FDA 510(k) clearance to market the ROSA® Knee System for robotically-assisted total knee replacement. Jan 02, 2019
Study Results: InSpace Balloon vs. Superior Capsular Reconstruction
Results from cadaveric study of OrthoSpace's InSpace balloon spacer vs. superior capsular reconstruction in the treatment of rotator cuff tears found that InSpace effectively restored the humeral head to a nearly normal position. Dec 19, 2018
Medtronic Completes Acquisition of Mazor Robotics
Medtronic completed its planned acquisition of Mazor Robotics in a transaction valued at US $1.7BB. Dec 19, 2018
Smith & Nephew Acquiring Ceterix, Meniscal Repair Technology
Smith & Nephew entered into an agreement to acquire Ceterix Orthopaedics, developer of NovoStitch®Pro Meniscal Repair, for up to US $105MM. The transaction is expected to close in early 2019. Dec 18, 2018
Episurf Medical Gains FDA Approval for IDE Study
Episurf Medical received FDA approval for its IDE application to commence a clinical study of the Episealer® knee device. Dec 17, 2018
